Compare EPSN & CVRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | EPSN | CVRX |
|---|---|---|
| Founded | 2005 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 187.2M | 160.8M |
| IPO Year | 2018 | 2021 |
| Metric | EPSN | CVRX |
|---|---|---|
| Price | $6.20 | $6.16 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $10.50 |
| AVG Volume (30 Days) | 171.1K | ★ 333.5K |
| Earning Date | 05-13-2026 | 05-11-2026 |
| Dividend Yield | ★ 4.01% | N/A |
| EPS Growth | N/A | ★ 23.02 |
| EPS | ★ 0.02 | N/A |
| Revenue | N/A | ★ $56,651,000.00 |
| Revenue This Year | N/A | $17.17 |
| Revenue Next Year | N/A | $17.69 |
| P/E Ratio | $310.75 | ★ N/A |
| Revenue Growth | N/A | ★ 10.45 |
| 52 Week Low | $4.20 | $4.37 |
| 52 Week High | $8.50 | $11.30 |
| Indicator | EPSN | CVRX |
|---|---|---|
| Relative Strength Index (RSI) | 51.02 | 40.86 |
| Support Level | $5.78 | $5.06 |
| Resistance Level | $6.49 | $8.25 |
| Average True Range (ATR) | 0.28 | 0.59 |
| MACD | 0.00 | -0.01 |
| Stochastic Oscillator | 51.31 | 38.45 |
Epsilon Energy Ltd is a North American on-shore focused independent natural gas and oil company engaged in the acquisition, development, gathering and production of natural gas and oil reserves. Its properties include Appalachian Basin-Pennsylvania, Permian Basin-Texas and New Mexico, Anadarko Basin-Oklahoma, Powder River Basin-Wyoming, Western Canadian Sedimentary Basin-Alberta, Canada. Its segments include The Upstream segment activities include acquisition, development and production of natural gas and oil reserves on properties within the United States and Canada; and The Gas Gathering segment partners with two other companies to operate a natural gas gathering system. The Upstream segment derives the majority of the revenue.
CVRx Inc is a commercial-stage medical device company focused on developing, manufacturing, and commercializing minimally invasive neuromodulation solutions for patients with cardiovascular diseases. Its proprietary platform technology, Barostim, is designed to leverage the power of the brain to address the imbalance of the Autonomic Nervous System, which causes heart failure and other cardiovascular diseases. Barostim provides Baroreflex Activation Therapy which in turn triggers an autonomic response to the heart. The majority of revenue is derived from the USA market.